Skip to content

microTargeting™ Platform MP-KIT-P-EO-00596Recalls & reported problems

Fhc, Inc. · microTargeting Epilepsy Platform, Multi-Oblique, 1x, nonsterile · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00873263005965), received between Jul 13, 2021 and May 28, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Inaccurate Information” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 2 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Inaccurate Information2
  • Use of Device Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 28, 2026Inaccurate Information

    A COMPLAINT WAS RECEIVED ON (B)(6) 2026, FOR A MULTI OBLIQUE EPILEPSY PLATFORM (MP-KIT-P-EO, SN (B)(6) USED ON (B)(6) 2026. THE REPORTING PHYSICIAN IDENTIFIED A DISCREPANCY BETWEEN THE DEPTH EMBOSSED ON THE PLATFORM (177 MM) AND THE CORRECT DEPTH PROVIDED IN THE PLANNING DOCUMENTATION (117 MM). THE DISCREPANCY WAS RECOGNIZED PRIOR TO USE, PREVENTING POTENTIAL MISPLACEMENT OF THE LEAD. INVESTIGATION DETERMINED THAT THE CORRECT DEPTH WAS PRESENT IN THE PLANNING SOFTWARE OUTPUTS AND MANUFACTURING DOCUMENTATION. THE DISCREPANCY WAS INTRODUCED DURING MANUAL TRANSCRIPTION OF DEPTH VALUES ONTO THE PLATFORM. DEVICE HISTORY RECORDS SHOWED ALL REQUIRED INSPECTIONS AND RELEASE STEPS WERE COMPLETED; HOWEVER, THE INCORRECT VALUE WAS NOT IDENTIFIED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25315475 ↗
  • MalfunctionMay 27, 2026Use of Device Problem

    ON (B)(6), 2026, AN SEEG PROCEDURE WAS PERFORMED WITH 14 PLANNED TRAJECTORIES AND ONE ADDITIONAL GROUND ELECTRODE, WHICH WAS NOT INCLUDED IN THE NAVIGATION PLAN. THE PROCEDURE WAS DELAYED AND BEGAN AT APPROXIMATELY 7:00 PM. MEASUREMENTS WERE PROVIDED INTRAOPERATIVELY FOR BOTH THE TRACKING STYLET AND THE IMPLANTABLE LEAD. THE TRACKING STYLET WAS ADVANCED TO THE INTENDED DEPTH RELATIVE TO THE PLATFORM HUB. IMPLANTABLE LEADS WERE THEN ADVANCED USING DEPTH MARKINGS ON THE LEAD IN CONJUNCTION WITH THE FIXATION BOLT. FOLLOWING PLACEMENT OF ALL LEADS, INTRAOPERATIVE CT IMAGING INDICATED THAT ALL WERE POSITIONED APPROXIMATELY 4-5 CM DEEPER THAN INTENDED. A CONFIRMATORY CT SCAN PERFORMED IN RADIOLOGY VERIFIED THE FINDING. ALL LEADS WERE SUBSEQUENTLY REMOVED. NO INTRACRANIAL HEMORRHAGE WAS IDENTIFIED ON IMAGING. THE PROCEDURE WAS DISCONTINUED AND NOT COMPLETED AS PLANNED. POST-PROCEDURE FOLLOW-UP AT APPROXIMATELY 72 HOURS INDICATED THE PATIENT EXPERIENCED NO ADVERSE EFFECTS OR COMPLICATIONS. THE PHYSICIAN ACKNOWLEDGED OPERATOR USE ERROR AS THE LIKELY CAUSE AND EXPRESSED INTENT TO PURSUE ADDITIONAL TRAINING PRIOR TO FUTURE USE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25305898 ↗
  • MalfunctionJul 13, 2021Inaccurate Information; Inaccurate Information

    WHILE USING A MP-KIT-P-EO (MULTIOBLIQUE (PMT) WAYPOINT STEREOTACTIC SYSTEM, PHYSICIAN FOUND THE PLATFORM WAS LABELED WITH THE INCORRECT DEPTH NUMBERS. THERE WAS NO HARM TO PATIENT AS PHYSICIAN IDENTIFIED THE ISSUE AND PROCEEDED ACCORDINGLY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12160501 ↗

Other Neurological stereotaxic Instrument devices

All Neurological stereotaxic Instrument devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.